Federico, Cinzia
Alhallak, Kinan http://orcid.org/0000-0002-0512-0357
Sun, Jennifer
Duncan, Kathleen
Azab, Feda
Sudlow, Gail P.
de la Puente, Pilar
Muz, Barbara
Kapoor, Vaishali http://orcid.org/0000-0002-7581-1487
Zhang, Luna
Yuan, Fangzheng
Markovic, Matea http://orcid.org/0000-0003-4228-194X
Kotsybar, Joseph
Wasden, Katherine
Guenthner, Nicole http://orcid.org/0000-0001-5730-4775
Gurley, Shannon
King, Justin
Kohnen, Daniel
Salama, Noha N. http://orcid.org/0000-0001-6329-952X
Thotala, Dinesh
Hallahan, Dennis E.
Vij, Ravi
DiPersio, John F.
Achilefu, Samuel http://orcid.org/0000-0002-3133-6717
Azab, Abdel Kareem http://orcid.org/0000-0002-6371-2780
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (TL1TR002344, UL1TR002345)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54CA199092, P50CA094056, P30CA091842)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 5 June 2019
Accepted: 23 October 2020
First Online: 27 November 2020
Competing interests
: A.K.A. and C.F. have filed a patent with regards to the technology described in this study. A.K.A. is the founder and owner of Targeted Therapeutics LLC and Cellatrix LLC; however, the aforementioned entities did not contribute to the current study. Other authors state no competing interests.